Terry A. Schwartz, MD

home / authors / terry-a-schwartz-md

Articles

Only 13% to 50% of AN patients are considered recovered 1 to 2 years posttreatment, and 20% to 30% develop a chronic, unremitting course of AN. How can we improve these outcomes?

Pharmacological Management of Treatment-Resistant Anorexia Nervosa

Mary Ellen Trunko, MD;Guido K.W. Frank, MD;Terry A. Schwartz, MD;Walter H. Kaye, MD

January 26th 2022

Only 13% to 50% of AN patients are considered recovered 1 to 2 years posttreatment, and 20% to 30% go on to develop a chronic and unremitting course of AN. How can we improve these outcomes?

Latest Updated Articles

Published: March 23rd 2021 | Updated: April 2nd 2025

Poor DSM-5—So Misunderstood!

Published: January 21st 2016 | Updated: April 2nd 2025

Mini Quiz: Methods of Suicide

Published: March 19th 2021 | Updated: April 2nd 2025

Mini Quiz: Treatment for Pedophilia?

Published: July 18th 2016 | Updated: April 2nd 2025

Mini Quiz: Suicide Risk in Veterans

Published: March 27th 2025 | Updated: April 2nd 2025

In Schizophrenia, Nicotine Enhances Cognitive Performance by Improving Brain Network Function

Published: March 25th 2025 | Updated: April 2nd 2025

Emotion and Cognitive Control: An Essential Partnership for Adaptive Behavior

Recent Content

New NDA Submitted: Bysanti to Treat Acute Bipolar I and Schizophrenia

Standing Up Against Hate: Let’s Be Foolish

Presenting Our April Theme: Sleep

The Psychiatric Pipeline in Review: Quarter 1, 2025

View More Recent Content

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777